Stock listing
Herantis Pharma Plc
Selected listing: HRTIS · OMXHEX · EUR · FI
Herantis Pharma Plc (Helsinki:HRTIS), Health Technology. Latest release Aug 10, 2026: Herantis Pharma Oyj : to publish financial statements for the first half…
- Ticker
- Helsinki:HRTIS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Helsinki
- Currency
- EUR
About Herantis Pharma Plc
Herantis Pharma Plc is a public company listed on the Finnish market under the ticker HRTIS. Herantis Pharma focuses on developing innovative therapies for neurological and other diseases.
Latest news from Herantis Pharma Plc
Herantis Pharma Oyj : to publish financial statements for the first half of 2026 on August 20, 2026 - invitation to webcast presentation
August 10, 2026
Herantis Pharma Oyj : to publish financial statements for the first half of 2026 on August 20, 2026 – invitation to webcast presentation
August 10, 2026
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
June 25, 2026
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
June 2, 2026
Herantis Pharma Oyj : reports positive FDA feedback and finalizes Phase 2a study design for HER-096
June 2, 2026